查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676763

皮肤填充剂和肉毒桿菌毒素市场按产品类型、材料、应用和最终用户划分 - 2025 年至 2030 年全球预测

Dermal Fillers & Botulinum Toxin Market by Product Type, Material, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计皮肤填充剂和肉毒桿菌毒素市场规模将在 2024 年达到 142.9 亿美元，2025 年达到 155 亿美元，到 2030 年将达到 234.9 亿美元，复合年增长率为 8.63%。

主要市场统计数据
基准年 2024 年 142.9亿美元
预计 2025 年 155亿美元
预测年份 2030 234.9亿美元
复合年增长率（%） 8.63%

在充满活力的美容和治疗解决方案领域，真皮填充剂和肉毒桿菌毒素市场正在迅速发展。过去几十年来，技术和治疗方法取得了重大进步，改变了市场格局。本介绍为深入了解重新定义产业标准的复杂市场动态、细分策略和区域发展奠定了基础。产品配方和递送技术的不断改进，加上对病人安全性和疗效的日益关注，正在刺激现有企业和新参与企业的创新。随着对微创和有效美容手术的需求不断增长，各个领域的相关人员都被迫适应日益复杂化、监管越来越严格和消费者期望不断变化等特征的市场。本报告全面介绍了从变革性变化和关键细分见解到区域亮点和可操作的建议，旨在为市场现状和未来发展提供清晰、明智的观点。

皮肤填充剂和肉毒桿菌毒素市场的转型

近年来，皮肤填充剂和肉毒桿菌毒素的市场模式发生了显着变化。生物技术和製剂科学的进步不仅提高了治疗效果，而且扩大了其在美容和治疗性介入的应用范围。从历史上看，传统方法一直占据市场主导地位，但随着研究和开发的活性化，新型配方不断涌现，可以提供更可预测的结果并降低副作用的风险。这种演变是显而易见的，因为现在的产品可以根据消费者的不同需求进行客製化，从细微的增强到更全面的脸部回春手术。消费者偏好的改变、对非手术程序的认识的不断提高以及技术的进步正在改变市场动态。行业领导者正在大力投资数位参与和个人化行销策略，以接触更多的消费者，同时监管机构不断更新标准以确保患者安全。技术创新、消费者需求和监管之间的动态交互作用凸显了当今市场的竞争激烈程度，并为未来的成长和投资奠定了坚实的基础。

影响市场策略的关键细分洞察

深入的市场研究将揭示有价值的细分见解，有助于推动您的目标策略。依产品类型，分为肉毒桿菌素製剂及皮肤填充剂，前者又分为肉毒桿菌素A至G製剂等多种类型。另一方面，根据皮肤填充剂的化学成分，皮肤填充剂又分为羟基磷灰石钙填充剂、透明质酸填充剂、PMMA（聚甲基丙烯酸甲酯）填充剂和聚乳酸填充剂。这些分类使得公司能够根据特定消费者的需求对其产品进行细分。基于材料的细分进一步将市场格局区分为生物分解性和非生物分解的填料，这一重要区别符合消费者对永续性和长期安全性不断变化的偏好。此外，按应用进行细分可发现两个主要途径。这些包括涉及脸颊增大、脸部轮廓矫正、唇部增强、疤痕治疗和减少皱纹等程序的美容应用，以及针对眼睑痉挛、颈部肌肌张力不全症、慢性偏头痛和膀胱过动症症等病症的治疗应用。除了产品动态之外，最终用户的细分涵盖各种医疗保健环境，例如皮肤科诊所、医院和专门的医疗水疗中心。这种多层次的方法提供了对市场的多方面视角，使相关人员能够根据产品创新和消费行为制定有针对性的策略。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 可支配收入的增加推动了个人和美容治疗支出的增加
      • 全球对微创和非手术美容手术的需求日益增加
      • 越来越多的老年人口将抗老疗程视为首选
    • 限制因素
      • 严格的法规结构减缓了新产品的推出
    • 机会
      • 开发更持久、更自然的真皮填充剂产品满足了消费者的需求
      • 线上咨询和电子商务平台的普及提高了注射剂的获取机会。
    • 任务
      • 与皮肤填充剂和肉毒桿菌毒素相关的併发症和副作用的风险
  • 市场区隔分析
    • 产品类型：肉毒桿菌毒素因其减少皱纹的能力而使用增加
    • 最终用户：皮肤科诊所凭藉其专业知识和对皮肤健康的关注，对皮肤填充剂和肉毒桿菌毒素的使用正在增加。
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章皮肤填充剂和肉毒桿菌毒素市场（依产品种类）

  • 肉毒桿菌毒素的种类
    • 肉毒桿菌毒素 A
    • 肉毒桿菌 B
    • 肉毒桿菌C
    • 肉毒毒素D
    • 肉毒桿菌 E
    • 肉毒桿菌毒素 F
    • 肉毒桿菌毒素G
  • 皮肤填充剂
    • 烃基磷灰石钙填充剂
    • 透明质酸填充剂
    • PMMA（聚甲基丙烯酸甲酯）填料
    • 聚乳酸填料

第 7 章皮肤填充剂和肉毒桿菌毒素市场（按材料）

  • 生物分解性填料
  • 非生物分解的填充剂

第 8 章皮肤填充剂和肉毒桿菌毒素市场（按应用）

  • 美学
    • 丰颊术
    • 脸部线条矫正
    • 丰唇
    • 疤痕治疗
    • 减少皱纹
  • 治疗
    • 眼睑痉挛
    • 颈部肌张力不全症
    • 慢性偏头痛
    • 膀胱过动症

第 9 章皮肤填充剂和肉毒桿菌毒素市场（按最终用户）

  • 皮肤科诊所
  • 医院
  • 医疗水疗

10. 美国皮肤填充剂和肉毒桿菌毒素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太地区皮肤填充剂和肉毒桿菌毒素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲皮肤填充剂和肉毒桿菌毒素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • AbbVie Inc.
  • Anika Therapeutics, Inc.
  • BMI KOREA CO., LTD.
  • BNC Global
  • CROMA-PHARMA GmbH
  • Crown Laboratories, Inc.
  • Daewoong Pharmaceutical Co., Ltd.
  • Evolus, Inc.
  • Galderma SA
  • Gufic Biosciences
  • Hugel, Inc.
  • Ipsen SA
  • LG Chem, Ltd.
  • Medytox, Inc.
  • Merz Pharmaceuticals GmbH
  • Prollenium Medical Technologies.
  • Reborn Aesthetic Clinic Pty Ltd
  • Sinclair Pharma Ltd.
  • TEOXANE SA
  • Tiger Aesthetics Medical, LLC
Product Code: MRR-867BED9A9E66

The Dermal Fillers & Botulinum Toxin Market was valued at USD 14.29 billion in 2024 and is projected to grow to USD 15.50 billion in 2025, with a CAGR of 8.63%, reaching USD 23.49 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 14.29 billion
Estimated Year [2025] USD 15.50 billion
Forecast Year [2030] USD 23.49 billion
CAGR (%) 8.63%

In the dynamic world of aesthetic and therapeutic solutions, the dermal fillers and botulinum toxin market has experienced rapid evolution. The past couple of decades have seen significant advancements in technologies and treatment methodologies, leading to a transformative market landscape. This introduction sets the stage for a detailed exploration of the intricate market trends, segmentation strategies, and regional developments that have redefined industry standards. The continuous improvement in product formulations and delivery techniques, combined with an increasing focus on patient safety and efficacy, has propelled both established players and new entrants to innovate. As the demand for minimally invasive and effective aesthetic procedures grows, stakeholders across the spectrum are compelled to adapt to a market marked by sophistication, rigorous regulation, and evolving consumer expectations. This article unfolds a comprehensive narrative-from transformative shifts and key segmentation insights to regional highlights and actionable recommendations-designed to offer a clear, informed perspective on the market's current status and future trajectory.

Transformative Shifts in the Global Market Landscape

Recent years have brought about transformative shifts that have significantly altered the dermal fillers and botulinum toxin market landscape. Advances in biotechnology and formulation science have not only refined the efficacy of treatments but also expanded the range of applications in both aesthetics and therapeutic interventions. Historically, traditional approaches dominated the market; however, increased research and development have fostered the emergence of novel formulations that offer more predictable outcomes and reduced risk of side effects. This evolution is evident in the way products are now tailored to meet the diverse needs of consumers, ranging from subtle enhancements to more comprehensive facial rejuvenation procedures. Alongside technological advancements, changing consumer preferences and increased awareness about non-surgical procedures have driven a shift in market dynamics. Industry leaders are investing heavily in digital engagement and personalized marketing strategies to capture a broader audience, while regulatory authorities continue to update standards that ensure patient safety. Such dynamic interplay between innovation, consumer demand, and regulation underscores the competitive intensity in the market today, setting a robust stage for future growth and investment.

Key Segmentation Insights Shaping Market Strategies

A detailed examination of the market reveals valuable segmentation insights that are instrumental in driving targeted strategies. The product type segmentation distinguishes between botulinum toxin formulations and dermal fillers, with the former further categorized into diverse types which include formulations ranging from Botulinum Toxin A through G. On the other hand, dermal fillers are redistributed based on chemical composition into Calcium Hydroxylapatite Fillers, Hyaluronic Acid Fillers, PMMA (Polymethyl-Methacrylate) Fillers, and Polylactic Acid Fillers. These classifications provide companies with the nuanced ability to segment product offerings based on specific consumer needs. Material-based segmentation further differentiates the market landscape into biodegradable fillers and non-biodegradable fillers, an important distinction that aligns with evolving consumer preferences for sustainability and long-term safety. Additionally, application-based segmentation unveils two primary avenues: aesthetic applications, which involve procedures such as cheek augmentation, facial line correction, lip enhancement, scar treatment, and wrinkle reduction; and therapeutic applications, which address conditions like blepharospasm, cervical dystonia, chronic migraine, and overactive bladder. Beyond the product dynamics, segmentation by end user spans across various healthcare settings, including dermatology clinics, hospitals, and dedicated medical spas. This layered approach provides a multifaceted view of the market, enabling stakeholders to craft precise strategies based on both product innovation and consumer behavior.

Based on Product Type, market is studied across Botulinum Toxin Type and Dermal Fillers. The Botulinum Toxin Type is further studied across Botulinum Toxin A, Botulinum Toxin B, Botulinum Toxin C, Botulinum Toxin D, Botulinum Toxin E, Botulinum Toxin F, and Botulinum Toxin G. The Dermal Fillers is further studied across Calcium Hydroxylapatite Fillers, Hyaluronic Acid Fillers, PMMA (Polymethyl-Methacrylate) Fillers, and Polylactic Acid Fillers.

Based on Material, market is studied across Biodegradable Fillers and Non-Biodegradable Fillers.

Based on Application, market is studied across Aesthetics and Therapeutic. The Aesthetics is further studied across Cheek Augmentation, Facial Line Correction, Lip Enhancement, Scar Treatment, and Wrinkle Reduction. The Therapeutic is further studied across Blepharospasm, Cervical Dystonia, Chronic Migraine, and Overactive Bladder.

Based on End User, market is studied across Dermatology Clinics, Hospitals, and Medical Spas.

Global Regional Insights Informing Market Direction

Regional variations underscore significant differences in market maturity and consumer adoption, thereby shaping the overall strategy for product positioning and growth. In the Americas, robust economic frameworks and high healthcare spending combine with a proactive regulatory environment to foster rapid product adoption and innovation. The landscape in Europe, Middle East, and Africa reveals a blend of mature markets alongside emerging growth opportunities where new trends in aesthetic medicine are taking hold, driven by increased awareness and a growing demand for minimally invasive procedures. Meanwhile, the Asia-Pacific region presents a compelling growth story as rising disposable incomes, expanding healthcare infrastructures, and a cultural shift towards embracing non-surgical aesthetics fuel demand. These regional insights highlight the importance of localized market strategies while reinforcing the need for global innovation, as companies pivot to meet diverse consumer expectations and regulatory requirements across different geographies. Each region offers unique opportunities as well as challenges that require organizations to adopt flexible, yet robust, approaches to remain competitive in this multifaceted market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Driving Market Innovation

The competitive landscape is bolstered by a number of key companies that continue to play pivotal roles in shaping the direction of the market. Notable industry leaders include AbbVie Inc., Anika Therapeutics, Inc., BMI KOREA CO., LTD., and BNC Global, each bringing distinct strengths in research, development, and market penetration. CROMA-PHARMA GmbH, Crown Laboratories, Inc., and Daewoong Pharmaceutical Co., Ltd. have further fortified the industry with their innovative approaches, while Evolus, Inc. and Galderma S.A. drive quality improvements through continuous product enhancements and customer-centric solutions. The market's competitive edge is further sharpened by players such as Gufic Biosciences, Hugel, Inc., Ipsen S.A., and LG Chem, Ltd., who are known for their commitment to excellence in both product efficacy and safety. Companies like Medytox, Inc., Merz Pharmaceuticals GmbH, Prollenium Medical Technologies, Reborn Aesthetic Clinic Pty Ltd, Sinclair Pharma Ltd., TEOXANE SA, and Tiger Aesthetics Medical, LLC also contribute significantly to the innovation landscape, ensuring a steady infusion of breakthrough treatments and advanced technologies. Collectively, these companies not only enhance the market's competitiveness but also drive the overall evolution of aesthetic and therapeutic treatment modalities.

The report delves into recent significant developments in the Dermal Fillers & Botulinum Toxin Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Anika Therapeutics, Inc., BMI KOREA CO., LTD., BNC Global, CROMA-PHARMA GmbH, Crown Laboratories, Inc., Daewoong Pharmaceutical Co., Ltd., Evolus, Inc., Galderma S.A., Gufic Biosciences, Hugel, Inc., Ipsen S.A., LG Chem, Ltd., Medytox, Inc., Merz Pharmaceuticals GmbH, Prollenium Medical Technologies., Reborn Aesthetic Clinic Pty Ltd, Sinclair Pharma Ltd., TEOXANE SA, and Tiger Aesthetics Medical, LLC. Strategic Recommendations to Capitalize on Market Opportunities

Industry leaders are encouraged to adopt proactive strategies to harness the prevailing market opportunities. It is imperative to invest in advanced research and development to pioneer next-generation formulations that address both aesthetic and therapeutic needs. Emphasis should be placed on ensuring product safety and efficacy, a factor that has become central to consumer decision-making in this market. Companies should consider expanding their product portfolios to encompass the entire spectrum of injectable treatments, thereby appealing to a broader range of demographics. Furthermore, establishing strategic partnerships and collaborations can facilitate faster technology adoption and improve market penetration, especially in emerging regions. Leaders should also focus on digital transformation by leveraging data analytics to tailor marketing strategies that resonate with specific consumer segments. On the operational front, optimizing supply chain logistics and quality control measures will be pivotal in maintaining a competitive edge. Engaging in active dialogue with regulatory authorities and participating in industry forums can also provide early insights into evolving standards and best practices. Through these actions, companies can not only secure immediate market gains but also lay a sustainable foundation for long-term growth.

Concluding Observations on Market Evolution

In summary, the dermal fillers and botulinum toxin market is undergoing a period of robust transformation fueled by innovations in product development, evolving consumer expectations, and shifting regulatory landscapes. The comprehensive segmentation insights illustrate how varied product offerings, application areas, and end-user requirements collectively contribute to a dynamic, multilingual market environment. Regional disparities further highlight that while some markets are mature and competitive, others offer substantial growth potential driven by increasing demand and infrastructural investments. Overall, industry leaders who are able to navigate these complexities with informed strategies and agile operational practices are well positioned to capitalize on emerging opportunities. The integration of cutting-edge technology with strategic market insights will undoubtedly continue to propel the market forward, ensuring that patient outcomes and product performance remain at the forefront of innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing disposable income contributing to higher expenditure on personal and aesthetic treatments
      • 5.1.1.2. Growing demand for minimally invasive and non-surgical aesthetic procedures worldwide
      • 5.1.1.3. Increasing prevalence of aging population seeing anti-aging treatments as preferred options
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory frameworks delay the approval and introduction of new products
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of longer-lasting and more natural-looking dermal filler products meets consumer demands
      • 5.1.3.2. Increased availability of online consultations and e-commerce platforms enhancing accessibility to injectables
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of complications and side effects associated with dermal fillers & botulinum toxin
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising utilization of botulinum toxin due to its efficacy in reducing the appearance of wrinkles
    • 5.2.2. End User: Growing usage of dermal fillers & botulinum toxin in dermatology clinics due to their specialized expertise and focus on skin health
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dermal Fillers & Botulinum Toxin Market, by Product Type

  • 6.1. Introduction
  • 6.2. Botulinum Toxin Type
    • 6.2.1. Botulinum Toxin A
    • 6.2.2. Botulinum Toxin B
    • 6.2.3. Botulinum Toxin C
    • 6.2.4. Botulinum Toxin D
    • 6.2.5. Botulinum Toxin E
    • 6.2.6. Botulinum Toxin F
    • 6.2.7. Botulinum Toxin G
  • 6.3. Dermal Fillers
    • 6.3.1. Calcium Hydroxylapatite Fillers
    • 6.3.2. Hyaluronic Acid Fillers
    • 6.3.3. PMMA (Polymethyl-Methacrylate) Fillers
    • 6.3.4. Polylactic Acid Fillers

7. Dermal Fillers & Botulinum Toxin Market, by Material

  • 7.1. Introduction
  • 7.2. Biodegradable Fillers
  • 7.3. Non-Biodegradable Fillers

8. Dermal Fillers & Botulinum Toxin Market, by Application

  • 8.1. Introduction
  • 8.2. Aesthetics
    • 8.2.1. Cheek Augmentation
    • 8.2.2. Facial Line Correction
    • 8.2.3. Lip Enhancement
    • 8.2.4. Scar Treatment
    • 8.2.5. Wrinkle Reduction
  • 8.3. Therapeutic
    • 8.3.1. Blepharospasm
    • 8.3.2. Cervical Dystonia
    • 8.3.3. Chronic Migraine
    • 8.3.4. Overactive Bladder

9. Dermal Fillers & Botulinum Toxin Market, by End User

  • 9.1. Introduction
  • 9.2. Dermatology Clinics
  • 9.3. Hospitals
  • 9.4. Medical Spas

10. Americas Dermal Fillers & Botulinum Toxin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Dermal Fillers & Botulinum Toxin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Dermal Fillers & Botulinum Toxin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Allergan Aesthetics pioneers Botox approval for masseter muscle prominence treatment in China, eyeing global expansion
    • 13.3.2. Crown Laboratories strengthens competitive position in aesthetic and therapeutic markets through USD 924 million purchase of Revance Therapeutics
    • 13.3.3. Merz Aesthetics sets industry benchmark with groundbreaking FDA approval for XEOMIN treating upper facial lines
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Anika Therapeutics, Inc.
  • 3. BMI KOREA CO., LTD.
  • 4. BNC Global
  • 5. CROMA-PHARMA GmbH
  • 6. Crown Laboratories, Inc.
  • 7. Daewoong Pharmaceutical Co., Ltd.
  • 8. Evolus, Inc.
  • 9. Galderma S.A.
  • 10. Gufic Biosciences
  • 11. Hugel, Inc.
  • 12. Ipsen S.A.
  • 13. LG Chem, Ltd.
  • 14. Medytox, Inc.
  • 15. Merz Pharmaceuticals GmbH
  • 16. Prollenium Medical Technologies.
  • 17. Reborn Aesthetic Clinic Pty Ltd
  • 18. Sinclair Pharma Ltd.
  • 19. TEOXANE SA
  • 20. Tiger Aesthetics Medical, LLC

LIST OF FIGURES

  • FIGURE 1. DERMAL FILLERS & BOTULINUM TOXIN MARKET MULTI-CURRENCY
  • FIGURE 2. DERMAL FILLERS & BOTULINUM TOXIN MARKET MULTI-LANGUAGE
  • FIGURE 3. DERMAL FILLERS & BOTULINUM TOXIN MARKET RESEARCH PROCESS
  • FIGURE 4. DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. DERMAL FILLERS & BOTULINUM TOXIN MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. DERMAL FILLERS & BOTULINUM TOXIN MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DERMAL FILLERS & BOTULINUM TOXIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DERMAL FILLERS & BOTULINUM TOXIN MARKET DYNAMICS
  • TABLE 7. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN D, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN E, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN F, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN G, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY CALCIUM HYDROXYLAPATITE FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY HYALURONIC ACID FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PMMA (POLYMETHYL-METHACRYLATE) FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY POLYLACTIC ACID FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BIODEGRADABLE FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY NON-BIODEGRADABLE FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY CHEEK AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY FACIAL LINE CORRECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY LIP ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY SCAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY WRINKLE REDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BLEPHAROSPASM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY CERVICAL DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY CHRONIC MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)

TABLE 306.